Effective treatment of severe COVID-19 patients with tocilizumab

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

2020 • 10,196 citations

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

2020 • 9,328 citations

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

2020 • 8,517 citations

Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group

2020 • 1,363 citations

Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients

2020 • 1,073 citations

Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus

2017 • 920 citations

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

2008 • 782 citations

Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human

2005 • 724 citations

Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation

2013 • 669 citations

Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling

2011 • 654 citations

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

2013 • 624 citations

Interleukin-6 and its receptors: A highly regulated and dynamic system

2014 • 520 citations

Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment

2013 • 389 citations

Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response

2012 • 128 citations

Tocilizumab – A novel therapy for non-organ-specific autoimmune diseases

2012 • 83 citations

Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T Cells

2017 • 61 citations

Clinical experience of IL-6 blockade in rheumatic diseases—Implications on IL-6 biology and disease pathogenesis

2014 • 39 citations

Cited By (0)

No citing papers found in database